IP Library Granted Patent US 8,093,364
Granted Patent B2
US 8,093,364 · App. 12/355,665 · Granted Jan 10, 2012

Enhanced purification of antibodies and antibody fragments by apatite chromatography

Assignee: Bio-Rad Laboratories, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,093,364
App. No.
12/355,665
Granted
Jan 10, 2012
Kind
B2
Abstract

Methods are disclosed for use of apatite chromatography, particularly without reliance upon phosphate gradients, for purification or separation of at least one intact non-aggregated antibody, or at least one immunoreactive antibody fragment, from an impure preparation. Integration of such methods into multi-step procedures with other fractionation methods are additionally disclosed.

Claims (7)

1. A method for purifying at least one non-aggregated antibody or at least one F(ab′) 2 antibody fragment from an impure preparation containing said antibody or antibody fragment comprising:

(a) contacting the impure preparation with an apatite chromatography support, wherein the apatite chromatography support is in a calcium-derivatized form when it is contacted with the impure preparation containing said antibody or antibody fragment and wherein the antibody or antibody fragment binds to the calcium-derivatized form of the apatite chromatography support; and

(b) substantially converting the calcium-derivatized apatite chromatography support to the support's native form, thereby forming a native form apatite chromatography support; and subsequently

(c) eluting the antibody or antibody fragment.

2. The method of claim 1 , wherein the native form apatite chromatography support is eluted with phosphate as the primary eluting ion.

3. The method of claim 1 , wherein the impure preparation contains the antibody and the antibody is eluted in the eluting step.

4. The method of claim 1 , wherein the impure preparation contains the antibody fragment and the antibody fragment is eluted in the eluting step.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 1, 2010
From: GAGNON, PETER S.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 024466/0208 →
Continuity (7)
Provisional Application 61011513 · Jan 18, 2008
Provisional Application 61062663 · Jan 28, 2008
Provisional Application 61069859 · Mar 19, 2008
Provisional Application 61070841 · Mar 27, 2008
Provisional Application 61135787 · Jul 24, 2008
Provisional Application 61189467 · Aug 20, 2008
Related Publication 20090187005A1 · Jul 23, 2009